North America Hydrocephalus Shunts Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Age Group, Type, Product, and End User

List of Tables

The North America hydrocephalus shunts market is expected to grow from US$ 122.61 million in 2022 to US$ 150.64 million by 2028. It is estimated to record a CAGR of 3.5% from 2022 to 2028.

Increasing Prevalence of Hydrocephalus Bolsters North America Hydrocephalus Shunts Market Growth

Cerebrospinal fluid (CSF) in the brain and spinal cord protects the central nervous system from injuries and infections. The accumulation of excess CSF in brain cavities adds to intracranial pressure, thereby leading to hydrocephalus. The condition may further lead to macrocephaly and cognitive dysfunctions. Hydrocephalus is more prevalent in children and infants than in the adult population. The disease is also prevalent in people aged 60 and above. According to the Hydrocephalus Association, the disease affects over 1 million Americans. Additionally, the incidence rate of hydrocephalus in the US is 1 in every 770 babies. The treatment approach of hydrocephalus highly focuses on managing CSF through medical devices named shunts. The shunt systems remove excess cerebrospinal fluid from the brain and divert it to other body parts, wherein it is absorbed as a part of the circulatory process. Thus, the high incidence of hydrocephalus drives the demand for hydrocephalus shunts, thereby boosting the North America hydrocephalus shunts market growth.

Market Overview

The North America hydrocephalus shunts market has been segmented into the US, Canada, and Mexico. The US is the key contributor to the market in this region. The market growth in this region is attributed to the rise in health concerns with increasing neurological disease incidence and the availability of a well-developed healthcare structure. According to the Hydrocephalus Organization, hydrocephalus is a neurological disorder that affects 1 out of 770 new-born and 1 out of 100 senior citizens in America. Furthermore, high investments by key medical companies in the R&D of neurosurgical devices to lower the socioeconomic burden of hydrocephalus boost the market growth in North America.

North America Hydrocephalus Shunts Market Revenue and Forecast to 2028 (US$ Million)

North America Hydrocephalus Shunts Market Segmentation

The North America hydrocephalus shunts market is segmented on the basis of age group, type, product, end user and country.

Based on age group, the North America hydrocephalus shunts market is bifurcated into pediatric and adults. The pediatric segment is expected to hold a larger market share in 2022.

In terms of type, the North America hydrocephalus shunts market is segmented into ventriculo-peritoneal, ventriculo-atrial, ventriculo-pleural, and lumbo-peritonea. The ventriculo-peritoneal segment would hold the largest market share in 2022.

The North America hydrocephalus shunts market, by product, is segmented into hydrocephalus valves, hydrocephalus catheters, neuronavigation systems, and others. The hydrocephalus valves segment is expected to dominate the market in 2022.

Based on end user, the North America hydrocephalus shunts market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment is likely to dominate the market in 2022.

In terms of country, the North America hydrocephalus shunts market is segmented into US, Canada, and Mexico. The US is expected to dominate the market in 2022.

B. Braun Melsungen AG (CHRISTOPH MIETHKE GMBH & CO. KG); Sophysa; HpBio Proteses, inc. ; Integra LifeSciences Holdings Corporation; KANEKA MEDIX CORP.; Medtronic; Natus Medical Incorporated; and Spiegelberg GmbH & Co. KG. are the leading companies operating in the North America hydrocephalus shunts market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America hydrocephalus shunts market
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in North America hydrocephalus shunts market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

Product Code: BMIRE00027769

1. Introduction

1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 North America Hydrocephalus Shunts Market - By Product
- 1.3.2 North America Hydrocephalus Shunts Market - By Type
- 1.3.3 North America Hydrocephalus Shunts Market - By Age Group
- 1.3.4 North America Hydrocephalus Shunts Market - By End User
- 1.3.5 North America Hydrocephalus Shunts Market - By Country

2. North America Hydrocephalus Shunts Market- Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Hydrocephalus Shunts Market - Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 North America - PEST Analysis
4.3 Expert Opinion

5. North America Hydrocephalus Shunts Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Prevalence of Hydrocephalus
- 5.1.2 Advancements in Hydrocephalus Valves
5.2 Market Restraints
- 5.2.1 High Cost of Treatments Involving Shunts and Needs for Revision Surgeries
5.3 Market Opportunities
- 5.3.1 Increasing Funding by Public and Private Organizations
5.4 Future Trends
- 5.4.1 Business Synergy Through Strategic Alliances
5.5 Impact Analysis

6. Hydrocephalus Shunts Market - North America Analysis

6.1 North America Hydrocephalus Shunts Market Revenue Forecast & Analysis
- 6.1.1 North America: Hydrocephalus Shunts Market, 2019-2028 (US$ Million)

7. North America Hydrocephalus Shunts Market Analysis - By Product

7.1 Overview
7.2 North America Hydrocephalus Shunts Market Revenue Share, by Product (2021 & 2028)
- 7.2.1 North America: Hydrocephalus Shunts Market, By Product, 2019-2028 (US$ Million)
  - 7.2.1.1 North America: Hydrocephalus Shunts Market, By Hydrocephalus Valves, 2019-2028 (US$ Million)
7.3 Hydrocephalus Valves
- 7.3.1 Overview
- 7.3.2 North America Hydrocephalus Valves: Hydrocephalus Shunts Market- Revenue and Forecast to 2028 (US$ Million)
  - 7.3.2.1 Adjustable Pressure Valves
    - 7.3.2.1.1 Overview
    - 7.3.2.1.2 North America Adjustable Pressure Valves: Hydrocephalus Shunts Market- Revenue and Forecast to 2028 (US$ Million)
  - 7.3.2.2 Fix Pressure Valves
    - 7.3.2.2.1 Overview
    - 7.3.2.2.2 North America Fix Pressure Valves: Hydrocephalus Shunts Market- Revenue and Forecast to 2028 (US$ Million)
7.4 Hydrocephalus Catheters
- 7.4.1 Overview
- 7.4.2 North America Hydrocephalus Catheters: Hydrocephalus Shunts Market- Revenue and Forecast to 2028 (US$ Million)
7.5 Neuronavigation Systems
- 7.5.1 Overview
- 7.5.2 North America Neuronavigation Systems: Hydrocephalus Shunts Market- Revenue and Forecast to 2028 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 North America Others: Hydrocephalus Shunts Market- Revenue and Forecast to 2028 (US$ Million)

8. North America Hydrocephalus Shunts Market Analysis - By Type

8.1 Overview
8.2 North America Hydrocephalus Shunts Market Revenue Share, by Type (2021 & 2028)
- 8.2.1 North America: Hydrocephalus Shunts Market, By Type, 2019-2028 (US$ Million)
8.3 Ventriculo-Peritoneal
- 8.3.1 Overview
- 8.3.2 North America Ventriculo-Peritoneal: Hydrocephalus Shunts Market- Revenue and Forecast to 2028 (US$ Million)
8.4 Ventriculo-Atrial
- 8.4.1 Overview
- 8.4.2 North America Ventriculo-Atrial: Hydrocephalus Shunts Market- Revenue and Forecast to 2028 (US$ Million)
8.5 Ventriculo-Pleural
- 8.5.1 Overview
- 8.5.2 North America Ventriculo-Pleural: Hydrocephalus Shunts Market- Revenue and Forecast to 2028 (US$ Million)
8.6 Lumbo-Peritoneal
- 8.6.1 Overview
- 8.6.2 North America Lumbo-Peritoneal: Hydrocephalus Shunts Market- Revenue and Forecast to 2028 (US$ Million)

9. North America Hydrocephalus Shunts Market Analysis - By Age Group

9.1 Overview
9.2 North America Hydrocephalus Shunts Market Revenue Share, by Age Group (2021 & 2028)
- 9.2.1 North America: Hydrocephalus Shunts Market, By Age Group, 2019-2028 (US$ Million)
9.3 Pediatric
- 9.3.1 Overview
- 9.3.2 North America Pediatric: Hydrocephalus Shunts Market- Revenue and Forecast to 2028 (US$ Million)
9.4 Adults
- 9.4.1 Overview
- 9.4.2 North America Adults: Hydrocephalus Shunts Market- Revenue and Forecast to 2028 (US$ Million)

10. North America Hydrocephalus Shunts Market - By End User

10.1 Overview
10.2 North America Hydrocephalus Shunts Market, by End User, 2021 and 2028 (%)
- 10.2.1 North America: Hydrocephalus Shunts Market, By End User, 2019-2028 (US$ Million)
10.3 Hospitals
- 10.3.1 Overview
- 10.3.2 North America Hospitals: Hydrocephalus Shunts Market - Revenue and Forecast to 2028 (US$ Million)
10.4 Ambulatory Surgical Centers
- 10.4.1 Overview
- 10.4.2 North America Ambulatory Surgical Centers: Hydrocephalus Shunts Market - Revenue and Forecast to 2028 (US$ Million)
10.5 Others
- 10.5.1 Overview
- 10.5.2 North America Others: Hydrocephalus Shunts Market - Revenue and Forecast to 2028 (US$ Million)

11. North America Hydrocephalus Shunts Market Revenue and Forecasts to 2028 - Country Analysis

11.1 North America: North America Hydrocephalus Shunts Market
- 11.1.1 Overview
- 11.1.2 North America: Hydrocephalus Shunts Market, by Country, 2021 & 2028 (%)
  - 11.1.2.1 US: Hydrocephalus Shunts Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.2.1.1 Overview
    - 11.1.2.1.2 US: Hydrocephalus Shunts Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.2.1.3 US: Hydrocephalus Shunts Market, By Product, 2019-2028 (US$ Million)
    - 11.1.2.1.3.1 US: Hydrocephalus Shunts Market, By Hydrocephalus Valves, 2019-2028 (US$ Million)
    - 11.1.2.1.4 US: Hydrocephalus Shunts Market, By Type, 2019-2028 (US$ Million)
    - 11.1.2.1.5 US: Hydrocephalus Shunts Market, By Age Group, 2019-2028 (US$ Million)
    - 11.1.2.1.6 US: Hydrocephalus Shunts Market, By End User, 2019-2028 (US$ Million)
  - 11.1.2.2 Canada: Hydrocephalus Shunts Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.2.2.1 Overview
    - 11.1.2.2.2 Canada: Hydrocephalus Shunts Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.2.2.3 Canada: Hydrocephalus Shunts Market, By Product, 2019-2028 (US$ Million)
    - 11.1.2.2.3.1 Canada: Hydrocephalus Shunts Market, By Hydrocephalus Valves, 2019-2028 (US$ Million)
    - 11.1.2.2.4 Canada: Hydrocephalus Shunts Market, By Type, 2019-2028 (US$ Million)
    - 11.1.2.2.5 Canada: Hydrocephalus Shunts Market, By Age Group, 2019-2028 (US$ Million)
    - 11.1.2.2.6 Canada: Hydrocephalus Shunts Market, By End User, 2019-2028 (US$ Million)
  - 11.1.2.3 Mexico: Hydrocephalus Shunts Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.2.3.1 Overview
    - 11.1.2.3.2 Mexico: Hydrocephalus Shunts Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.2.3.3 Mexico: Hydrocephalus Shunts Market, By Product, 2019-2028 (US$ Million)
    - 11.1.2.3.3.1 Mexico: Hydrocephalus Shunts Market, By Hydrocephalus Valves, 2019-2028 (US$ Million)
    - 11.1.2.3.4 Mexico: Hydrocephalus Shunts Market, By Type, 2019-2028 (US$ Million)
    - 11.1.2.3.5 Mexico: Hydrocephalus Shunts Market, By Age Group, 2019-2028 (US$ Million)
    - 11.1.2.3.6 Mexico: Hydrocephalus Shunts Market, By End User, 2019-2028 (US$ Million)

12. North America Hydrocephalus Shunts Market -Industry Landscape

12.1 Overview
12.2 Growth Strategies in the Hydrocephalus Shunts Market (%)
12.3 Organic Developments
- 12.3.1 Overview
12.4 Inorganic Developments
- 12.4.1 Overview

13. Company Profiles

13.1 B. Braun Melsungen AG (CHRISTOPH MIETHKE GMBH & CO. KG)
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Sophysa
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 HpBio Proteses, inc.
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Integra LifeSciences Holdings Corporation
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 KANEKA MEDIX CORP.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Medtronic
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Natus Medical Incorporated
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Spiegelberg GmbH & Co. KG
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments

14. Appendix

14.1 About The Insight Partners
14.2 Glossary of Terms